These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian study. Carpentieri A; Pacello L; De Marco IM; Loiacono A; Picconi O; Loconsole F J Dermatolog Treat; 2016 Oct; 27(5):399-405. PubMed ID: 26822691 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of treatment modalities for psoriasis. Tristani-Firouzi P; Krueger GG Cutis; 1998 Feb; 61(2 Suppl):11-21. PubMed ID: 9787987 [TBL] [Abstract][Full Text] [Related]
5. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. Armstrong AW; Read C JAMA; 2020 May; 323(19):1945-1960. PubMed ID: 32427307 [TBL] [Abstract][Full Text] [Related]
6. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation. Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130 [TBL] [Abstract][Full Text] [Related]
7. Psoriasis: current perspectives with an emphasis on treatment. Linden KG; Weinstein GD Am J Med; 1999 Dec; 107(6):595-605. PubMed ID: 10625029 [TBL] [Abstract][Full Text] [Related]
8. Comparative tolerability of systemic treatments for plaque-type psoriasis. McClure SL; Valentine J; Gordon KB Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213 [TBL] [Abstract][Full Text] [Related]
9. Psoriasis: state of the art 2013. de la Brassinne M; Nikkels A Acta Clin Belg; 2013; 68(6):433-41. PubMed ID: 24635331 [TBL] [Abstract][Full Text] [Related]
10. Ultraviolet B Phototherapy for Psoriasis: Review of Practical Guidelines. Mehta D; Lim HW Am J Clin Dermatol; 2016 Apr; 17(2):125-33. PubMed ID: 26872953 [TBL] [Abstract][Full Text] [Related]
11. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan. Feldman SR; Evans C; Russell MW J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166 [TBL] [Abstract][Full Text] [Related]
12. Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries. Busard CI; Cohen AD; Wolf P; Gkalpakiotis S; Cazzaniga S; Stern RS; Hutten BA; Feldhamer I; Quehenberger F; Lichem R; Kojanova M; Adenubiova E; Addis A; Naldi L; Spuls PI J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):245-253. PubMed ID: 28898541 [TBL] [Abstract][Full Text] [Related]
13. Novel therapies for psoriasis. Cather J; Menter A Am J Clin Dermatol; 2002; 3(3):159-73. PubMed ID: 11978137 [TBL] [Abstract][Full Text] [Related]
14. Advances in psoriasis treatment. Feldman S Dermatol Online J; 2000 Sep; 6(1):4. PubMed ID: 11328614 [TBL] [Abstract][Full Text] [Related]
15. Psoriasis treatment: traditional therapy. Lebwohl M; Ting PT; Koo JY Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii83-6. PubMed ID: 15708945 [TBL] [Abstract][Full Text] [Related]
16. 2023 guidelines on the management of psoriasis by the Dermatological Society of Singapore. Oon HH; Tan C; Aw DCW; Chong WS; Koh HY; Leung YY; Lim KS; Pan JY; Tan ES; Tan KW; Tham SN; Theng C; Wong SN Ann Acad Med Singap; 2024 Sep; 53(9):562-577. PubMed ID: 39373375 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it]. Stiefelhagen P MMW Fortschr Med; 2007 Sep; 149(35-36):12-4. PubMed ID: 17944277 [No Abstract] [Full Text] [Related]
18. What's new in the management of psoriasis? Kinney MA; Feldman SR G Ital Dermatol Venereol; 2009 Apr; 144(2):103-17. PubMed ID: 19357619 [TBL] [Abstract][Full Text] [Related]
19. The Evolving Landscape of Psoriasis Treatment. Armstrong AW; Gordon KB; Menter MA; Wu JJ Semin Cutan Med Surg; 2018 Feb; 37(2S):S39-S43. PubMed ID: 29614136 [TBL] [Abstract][Full Text] [Related]
20. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. Hugh J; Van Voorhees AS; Nijhawan RI; Bagel J; Lebwohl M; Blauvelt A; Hsu S; Weinberg JM J Am Acad Dermatol; 2014 Jan; 70(1):168-77. PubMed ID: 24184141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]